Blue Haven RX Review
Best for: people wanting flat all-inclusive compounded GLP-1 pricing with no charge until a doctor approves
Blue Haven RX is a telehealth weight-loss program offering compounded GLP-1 on flat monthly pricing: semaglutide at $179/month and tirzepatide at $259/month, with the cost covering the doctor consultation, prescription, medication and free shipping (intro offers run as low as $149/month). You fill out a questionnaire, a US-licensed physician reviews it and prescribes if you qualify, and you aren't charged until approved. Medications are compounded in 503A facilities. The operating entity is Eternum Health LLC, and third-party reviews are mixed.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Blue Haven RX is a solid telehealth option with balanced features and pricing.
How we scored Blue Haven RX
Each dimension is scored algorithmically from Blue Haven RX’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.3/10At $179/mo, Blue Haven RX runs about 6% above the $169 median for GLP-1 providers.
Effectiveness25%
7.6/10Blue Haven RX offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.3/10Online intake and platform experience — app/portal-based, consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.5/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-09).
Accessibility10%
5.6/10Blue Haven RX's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.4/10Blue Haven RX provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Blue Haven RX review
Last checked 2026-06-09- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Blue Haven RX offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Injectable | compounded injection | $179 |
| Injectable | compounded injection | $259 |
What we like
- Flat all-inclusive pricing — consult, prescription, medication and free shipping
- Not charged until a US-licensed physician approves your prescription
- Named operating entity disclosed (Eternum Health LLC)
- Both compounded semaglutide and tirzepatide listed as in-stock
Watch-outs
- Mixed third-party reviews — Trustpilot complaints on customer service and dosing
- Doesn't publish the states it serves or specific pharmacy partners
- No clearly verifiable accreditation badge (e.g. LegitScript) on the site
- Compounded semaglutide and tirzepatide only — no brand-name or oral options
Is Blue Haven RX worth it? Our verdict
Blue Haven RX positions itself around one thing: people wanting flat all-inclusive compounded GLP-1 pricing with no charge until a doctor approves. It runs $179/month.
How much Blue Haven RX actually costs
- semaglutide — $179/month
- tirzepatide — $259/month
That's roughly in line with the ~$169/month median across the GLP-1 providers we track.
Medications: what Blue Haven RX prescribes
Blue Haven RX prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes.
Who Blue Haven RX is best for — and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Blue Haven RX dispenses through an accredited compounding pharmacy. We found no FDA warning letters on file for the provider. We explain how we weigh medical oversight and compliance in our scoring methodology.
Bottom line
Blue Haven RX is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
Ready to start with Blue Haven RX?
Starting at $179/month. See current pricing and start your free consultation.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Blue Haven RX review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Blue Haven RX
Editorial score · methodology
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Blue Haven RX?
Starting at $179/month. See current pricing and start your free consultation.